Access cutting-edge systemic mastocytosis treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access systemic mastocytosis specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related systemic mastocytosis treatment provided free
This is an open-label, two-part Phase 2 study investigating CGT9486 for the treatment of patients with Advanced Systemic Mastocytosis (AdvSM), including patients with Aggressive SM (ASM), SM with Associated Hematologic Neoplasm (SM-AHN), and Mast Cell Leukemia (MCL).
Sponsor: Cogent Biosciences, Inc.
Check if you qualify for this systemic mastocytosis clinical trial in Boston, MA
If you're searching for systemic mastocytosis treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced systemic mastocytosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.